Letter/Comment
The latest advocacy letters and comments from the 黑料正能量 Association.
AHA's comments on the Centers for Medicare & Medicaid Services鈥 proposed rule regarding treatment of Medicare Advantage (MA)/Medicare Part C data in calculating a hospital鈥檚 disproportionate patient percentage (DPP) for fiscal years preceding fiscal year (FY) 2014.
AHA and other organizations representing the nation鈥檚 clinicians, hospitals, health systems and experts in health informatics and health information management yesterday urged the Department of Health and Human Services鈥 Office of the National Coordinator for Health Information Technology to allow鈥
AHA provides input on the Centers for Medicare & Medicaid Services鈥 Request for Information regarding electronic prescribing of controlled substances (EPCS).
The 黑料正能量 Association asks the Secretary of Health and Human Services (HHS) to reinstate the COVID-19 Provider Relief Fund (PRF) reporting requirements outlined in your June 19 frequently asked question that defined both expenses and lost revenues attributable to COVID-19.
Nearly 30 representatives encourage House leaders to modify in the next COVID-19 response package impending thresholds for qualifying participants in Advanced Alternative Payment Models, which they said threaten to 鈥渄erail鈥 the movement to value-based care under the Medicare Access and CHIP鈥
AHA Comments Submitted In Response to HRSA鈥檚 RFI on Health Professional Shortage Area (HPSA) Scoring
AHA's input on the Health Resources and Services Administration鈥檚 (HRSA) Health Professional Shortage Area (HPSA) Scoring Criteria request for information (RFI). The RFI solicits comments on the HPSA scoring methodology, including the criteria and measures utilized in calculating the scores.
The AHA requests that the Department of Health and Human Services revise certain FAQs that place problematic restrictions on the use of some CARES Act Provider Relief Fund dollars.
AHA comments on the National Academies of Sciences, Engineering and Medicine鈥檚 Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine.
AHA to HHS again expressing concern with recent actions taken by several major drug manufacturers to limit the distribution of certain 340B drugs to our hospital members.
AHA urges the Centers for Medicare & Medicaid Services (CMS) to withdraw the condition of participation that hospitals report daily COVID-19 data.